CatalystFDA/Bio

Cytokinetics (CYTK) Reaches A Phase 3 First In Non Obstructive HCM

Phase 3 first in non-obstructive HCM marks a pivotal clinical milestone for Cytokinetics.

What changed

Phase 3 first in non-obstructive HCM marks a pivotal clinical milestone for Cytokinetics.

Why it matters

Phase 3 first in non-obstructive HCM marks a pivotal clinical milestone for Cytokinetics. — impact context not separately stored; see What changed.

Sources